MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,802,000 | +89455.6% | 1,900,000 | 0.0% | 2.38% | +2.8% |
| Q2 2023 | $50,027 | +43.1% | 1,900,000 | 0.0% | 2.32% | +35.1% |
| Q1 2023 | $34,960 | -99.9% | 1,900,000 | 0.0% | 1.72% | +10.8% |
| Q4 2022 | $29,393,000 | -22.8% | 1,900,000 | 0.0% | 1.55% | -27.6% |
| Q3 2022 | $38,057,000 | -11.5% | 1,900,000 | 0.0% | 2.14% | -21.4% |
| Q2 2022 | $43,016,000 | -14.4% | 1,900,000 | 0.0% | 2.72% | +5.5% |
| Q1 2022 | $50,236,000 | -16.9% | 1,900,000 | 0.0% | 2.58% | +10.0% |
| Q4 2021 | $60,420,000 | +44.5% | 1,900,000 | 0.0% | 2.35% | +60.8% |
| Q3 2021 | $41,800,000 | +4.4% | 1,900,000 | 0.0% | 1.46% | +3.4% |
| Q2 2021 | $40,033,000 | +0.9% | 1,900,000 | 0.0% | 1.41% | +4.9% |
| Q1 2021 | $39,691,000 | +58.6% | 1,900,000 | +33.1% | 1.35% | +67.2% |
| Q4 2020 | $25,030,000 | – | 1,427,849 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |